1. Home
  2. FSK vs ALKS Comparison

FSK vs ALKS Comparison

Compare FSK & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSK
  • ALKS
  • Stock Information
  • Founded
  • FSK 2007
  • ALKS 1987
  • Country
  • FSK United States
  • ALKS Ireland
  • Employees
  • FSK N/A
  • ALKS N/A
  • Industry
  • FSK Investment Managers
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSK Finance
  • ALKS Health Care
  • Exchange
  • FSK Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • FSK 5.4B
  • ALKS 5.1B
  • IPO Year
  • FSK N/A
  • ALKS 1991
  • Fundamental
  • Price
  • FSK $20.63
  • ALKS $29.09
  • Analyst Decision
  • FSK Hold
  • ALKS Buy
  • Analyst Count
  • FSK 7
  • ALKS 12
  • Target Price
  • FSK $20.07
  • ALKS $40.00
  • AVG Volume (30 Days)
  • FSK 1.0M
  • ALKS 1.6M
  • Earning Date
  • FSK 08-05-2025
  • ALKS 07-23-2025
  • Dividend Yield
  • FSK 13.55%
  • ALKS N/A
  • EPS Growth
  • FSK N/A
  • ALKS N/A
  • EPS
  • FSK 1.90
  • ALKS 2.09
  • Revenue
  • FSK $1,687,000,000.00
  • ALKS $1,513,770,000.00
  • Revenue This Year
  • FSK N/A
  • ALKS N/A
  • Revenue Next Year
  • FSK N/A
  • ALKS $4.25
  • P/E Ratio
  • FSK $10.88
  • ALKS $13.92
  • Revenue Growth
  • FSK N/A
  • ALKS N/A
  • 52 Week Low
  • FSK $17.42
  • ALKS $22.90
  • 52 Week High
  • FSK $24.10
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • FSK 42.70
  • ALKS 38.82
  • Support Level
  • FSK $20.19
  • ALKS $29.26
  • Resistance Level
  • FSK $21.42
  • ALKS $30.52
  • Average True Range (ATR)
  • FSK 0.31
  • ALKS 0.78
  • MACD
  • FSK -0.12
  • ALKS -0.24
  • Stochastic Oscillator
  • FSK 27.36
  • ALKS 4.96

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: